Perrigo | PRGO - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Abbott USD 1.74B 23.39B 2025-09
Bayer EUR 982.42M 0 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Dr.Reddys Laboratories INR 832.69M 176K 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
J&J USD 2.41B 1.74M 2025-12
Merck USD 2.47B 12.72M 2025-12
Nestle CHF 2.57B 42.99M 2025-12
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 13M 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Reckitt Benckiser GBP 679.21M 605.21M 2025-06
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zoetis USD 420.35M 4.58M 2026-03